[1] 中国老年2型糖尿病防治临床指南编写组, 中国老年医学学会老年内分泌代谢分会, 中国老年保健医学研究会老年内分泌与代谢分会, 等. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中华内科杂志, 2022, 61(1):12-50. [2] Sinclair A J, Abdelhafiz A H, Rodríguez-Maas L. Frailty and sarcopenia-newly emerging and high impact complications of diabetes[J]. J Diabetes Complications, 2017, 31(9):1465-1473. [3] Anagnostis P, Gkekas N K, Achilla C, et al. Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis[J]. Calcif Tissue Int, 2020, 107(5):453-463. [4] Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient's mobility and independence[J]. Acta Diabetol, 2016, 53(6):879-889. [5] World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus[R]. Geneva:World Health Organization, 1999. [6] Baumgartner R N. Body composition in healthy aging[J]. Ann N Y Acad Sci, 2000, 904: 437-448. [7] 修双玲, 穆志静, 孙丽娜, 等. 老年2型糖尿病代谢综合征患者骨质疏松危险因素研究[J]. 首都医科大学学报, 2020, 41(1):108-112. [8] 王耀羚, 戚本玲, 刘丽华, 等. 老年综合评估相关项目与踝肱指数的关系研究[J]. 中国全科医学, 2021, 24(17):2163-2168. [9] Ceresini G, Marina M, Lauretani F, et al. Physical performance across the thyroid function values within the normal range in adult and older persons[J]. Aging Clin Exp Res, 2019, 31(3):385-391. [10] Garvey W T, Mechanick J I, Brett E M, et al. American association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity[J]. Endocr Pract, 2016, 22(Suppl 3):S201-S203. [11] Alberti K G M M, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition[J]. Lancet, 2005, 366(9491):1059-1062. [12] Mori H, Kuroda A, Ishizu M, et al. Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes[J]. J Diabetes Investig, 2019, 10(5):1332-1340. [13] Batsis J A, Barre L K, Mackenzie T A, et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004[J]. J Am Geriatr Soc, 2013, 61(6):974-980. [14] Wang H, Hai S, Liu Y X, et al. Associations between sarcopenic obesity and cognitive impairment in elderly Chinese community-dwelling individuals[J]. J Nutr Health Aging, 2019, 23(1):14-20. [15] Koster A, Ding J Z, Stenholm S, et al. Does the amount of fat mass predict age-related loss of lean mass, muscle strength, and muscle quality in older adults?[J]. J Gerontol A Biol Sci Med Sci, 2011, 66(8):888-895. [16] Choi K M. Sarcopenia and sarcopenic obesity[J]. Korean J Intern Med, 2016, 31(6):1054-1060. [17] Mu Z J, Fu J L, Sun L N, et al. Associations between homocysteine, inflammatory cytokines and sarcopenia in Chinese older adults with type 2 diabetes[J]. BMC Geriatr, 2021, 21(1):692. [18] Delgado C, Chertow G M, Kaysen G A, et al. Associations of body mass index and body fat with markers of inflammation and nutrition among patients receiving hemodialysis[J]. Am J Kidney Dis, 2017, 70(6):817-825. |